Status:
UNKNOWN
CHroniSense National Early Warning Score Study
Lead Sponsor:
BlueWind Medical
Conditions:
Clinical Assessment
Eligibility:
All Genders
18-120 years
Phase:
NA
Brief Summary
ChroniSense Medical Ltd. is developing a wearable medical multi-parametric monitoring system, Polso™. Polso™ provides a number of the parameters employed in various Early Warning Scores (EWS), such as...
Detailed Description
ChroniSense Medical Ltd. is developing a wearable medical multi-parametric monitoring system, Polso™. Polso™ provides a number of the parameters employed in various Early Warning Scores (EWS), such as...
Eligibility Criteria
Inclusion
- Participant is willing and able to give informed consent for participation in the study
- Male or female, aged 18 years or above
Exclusion
- Unable or unwilling to give valid consent for participation in the study
- Known history of allergy to nylon
- Current diagnosis of sustained or non-sustained ventricular/atrial arrhythmia (Ventricular tachycardia, supraventricular tachycardia, atrial fibrillation, bigeminy and trigeminy)
- Weak pulse
- Patients with infectious diseases requiring isolation such as Methicillin Resistant Staphylococcus Aureus (MRSA), Clostridium difficile and Extended Spectrum Beta-Lactamases (ESBL)
- Patients with implantable defibrillators, pacemakers or neurostimulators
- Patients with Parkinson disease or essential tremor
- Patients with poor Llead I ECG signal
Key Trial Info
Start Date :
June 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2019
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT03448861
Start Date
June 1 2018
End Date
November 1 2019
Last Update
April 24 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.